Clinical trials of riluzole in patients with ALS

Neurology

Volumn 47, Issue 4 SUPPL., 1996, Pages

  Miller, R G ^a   Bouchard, J P ^b   Duquette, P ^c   Eisen, A ^d   Gelinas, D ^a   Harati, Y ^e   Munsat, T L ^f   Powe, L ^g   Rothstein, J ^h   Salzman, P ^g   Sufit, R L ⁱ  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b LAVAL UNIVERSITY   (Canada)

^c NOTRE DAME HOSPITAL   (Canada)

^d VANCOUVER GENERAL HOSPITAL   (Canada)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f TUFTS MEDICAL CENTER   (United States)

^g SANOFI   (France)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; GLUTAMIC ACID; NEUROTROPHIC FACTOR; PLACEBO; RILUZOLE;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PARESTHESIA; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES; VERTIGO; VOMITING;

EID: 0007199084     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.47.4_suppl_2.86s     Document Type: Article

References (18)

1. Rothman SM, Thurston JH, Hauhart RE. Delayed neurotoxicity of excitatory amino acids in vitro. Neuroscience 1987;22:471-480.
2. Choi DW. Glutamate neurotoxicity and disease of the nervous system. Neuron 1988;1:623-634.
3. Plaitakis A, Caroscio JT. Abnormal glutamate metabolism in ALS [abstract]. Ann Neurol 1985;18:165.
4. Plaitakis A, Caroscio JT. Abnormal glutamate metabolism in amyotrophic lateral sclerosis. Ann Neurol 1987;22:575-579.
5. Perry TL, Hansen S, Jones K. Brain glutamate deficiency in amyotrophic lateral sclerosis. Neurology 1987;37:1845-1848.
6. Plaitakis A, Constantakakis E, Smith J. The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis. Ann Neurol 1988;24:446-449.
7. Rothstein JD, Martin LJ, Kuncl RW. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med 1992;326:1464-1468.
8. Rothstein J, Van Kammen M, Levey AI, Martin LJ, Kuncl RW. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 1995;38:73-84.
9. Rothstein JD, Jin L, Dykes-Hoberg M, Kuncl RW. Chronic glutamate uptake inhibition produces a model of slow neurotoxicity. Proc Natl Acad Sci USA 1993;90:6591-6595.
10. Estevez AG, Stutzmann JM, Barbeito L. Protective effect of riluzole on excitatory amino acid-mediated neurotoxicity on motoneuron-enriched cultures. Eur J Pharmacol 1995;280:47-53.
11. Rothstein JD, Kuncl RW. Neuroprotective strategies in a model of chronic glutamate-mediated motor neuron toxicity. J Neurochem 1995;65:643-651.
12. Hubert JP, Delumeau JC, Glowinski J, et al. Antagonism by riluzole of entry of calcium evoked by NMDA and veratridine in rat cultured granule cells: evidence for a dual mechanism of action. Br J Pharmacol 1994;113:261-267.
13. Herbert T, Drapeau P, Pradier L, et al. Block of the rat brain IIA sodium channel a subunit by the neuroprotective drug riluzole. Mol Pharmacol 1994:45:1055-1060.
14. Bensimon G, Lacomblez L, Meininger V, ALS/Riluzole Study Group. A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 1994;330:585-591.
15. Lacomblez L, Bensimon G, Leigh PN, ALS/Riluzole Study Group II. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Lancet 1996;347:1425-31.
16. Tarone RE. Tests for trend in life table analysis. Biometrika 1975;62:679-682.
17. Horowitz S, Patwardhan R, Marcus E. Hepatotoxic reactions associated with carbamazepine therapy. Epilepsia 1988;29:149-154.
18. Amato MP, Pracucci G, Ponziani G, Siracusa G, Fratiglioni L, Amaducci L. Long-term safety of azathioprine therapy in multiple sclerosis. Neurology 1993;43:831-833.